Similar articles for PMID: 32488392

Year	Number of Results
1901	1
1993	1
2002	1
2003	2
2004	2
2005	1
2006	4
2007	7
2008	11
2009	15
2010	8
2011	16
2012	16
2013	13
2014	9
2015	4
2016	14
2017	21
2018	27
2019	34
2020	65
2021	102
2022	71
2023	11

1

Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.

Alter BP, Best AF. Alter BP, et al. Breast Cancer Res Treat. 2020 Jul;182(2):465-476. doi: 10.1007/s10549-020-05710-6. Epub 2020 Jun 2. Breast Cancer Res Treat. 2020. PMID: 32488392

2

Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.

Sato K, Koyasu M, Nomura S, Sato Y, Kita M, Ashihara Y, Adachi Y, Ohno S, Iwase T, Kitagawa D, Nakashima E, Yoshida R, Miki Y, Arai M. Sato K, et al. Cancer Sci. 2017 Nov;108(11):2287-2294. doi: 10.1111/cas.13350. Epub 2017 Sep 18. Cancer Sci. 2017. PMID: 28796317 Free PMC article.

3

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.

Manchanda R, Patel S, Gordeev VS, Antoniou AC, Smith S, Lee A, Hopper JL, MacInnis RJ, Turnbull C, Ramus SJ, Gayther SA, Pharoah PDP, Menon U, Jacobs I, Legood R. Manchanda R, et al. J Natl Cancer Inst. 2018 Jul 1;110(7):714-725. doi: 10.1093/jnci/djx265. J Natl Cancer Inst. 2018. PMID: 29361001

4

Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.

Guénard F, Labrie Y, Ouellette G, Joly Beauparlant C, Simard J; INHERIT BRCAs; Durocher F. Guénard F, et al. J Hum Genet. 2008;53(7):579. doi: 10.1007/s10038-008-0285-z. Epub 2008 Apr 15. J Hum Genet. 2008. PMID: 18414782

5

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.

Kuusisto KM, Bebel A, Vihinen M, Schleutker J, Sallinen SL. Kuusisto KM, et al. Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832. Breast Cancer Res. 2011. PMID: 21356067 Free PMC article.

6

Fanconi Anemia.

Mehta PA, Ebens C. Mehta PA, et al. 2002 Feb 14 [updated 2021 Jun 3]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews^® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. 2002 Feb 14 [updated 2021 Jun 3]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews^® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. PMID: 20301575 Free Books & Documents. Review.

7

Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.

Yang XR, Devi BCR, Sung H, Guida J, Mucaki EJ, Xiao Y, Best A, Garland L, Xie Y, Hu N, Rodriguez-Herrera M, Wang C, Jones K, Luo W, Hicks B, Tang TS, Moitra K, Rogan PK, Dean M. Yang XR, et al. Breast Cancer Res Treat. 2017 Oct;165(3):687-697. doi: 10.1007/s10549-017-4356-8. Epub 2017 Jun 29. Breast Cancer Res Treat. 2017. PMID: 28664506 Free PMC article.

8

Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina.

Cerretini R, Mercado G, Morganstein J, Schiaffi J, Reynoso M, Montoya D, Valdéz R, Narod SA, Akbari MR. Cerretini R, et al. Breast Cancer Res Treat. 2019 Dec;178(3):629-636. doi: 10.1007/s10549-019-05411-9. Epub 2019 Aug 24. Breast Cancer Res Treat. 2019. PMID: 31446535

9

Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.

García MJ, Fernández V, Osorio A, Barroso A, Fernández F, Urioste M, Benítez J. García MJ, et al. Carcinogenesis. 2009 Nov;30(11):1898-902. doi: 10.1093/carcin/bgp218. Epub 2009 Sep 8. Carcinogenesis. 2009. PMID: 19737859

10

Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer.

Park JS, Lee ST, Nam EJ, Han JW, Lee JY, Kim J, Kim TI, Park HS. Park JS, et al. BMC Cancer. 2018 Jan 16;18(1):83. doi: 10.1186/s12885-017-3940-y. BMC Cancer. 2018. PMID: 29338689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed